Signup Crypto ETF Stocks News

Alphabet Inc. $GOOGL Shares Sold by Stock Yards Bank & Trust Co.

Stock Yards Bank & Trust Co. recently reduced its stake in Alphabet (GOOGL) by 2.4%, selling 11,355 shares, though it remains its third-largest holding. Despite this sale and insider selling, major institutions are adding to GOOGL, and analysts maintain a "Moderate Buy" consensus with an average price target of $368.25 following strong quarterly earnings and dividend announcement. Key positive sentiments include analyst upgrades, a long-term power deal, and AI product momentum for Google.

Source: MarketBeat
April 18, 2026 | 09:19:44
Category: General

Spirepoint Private Client LLC Purchases 3,449 Shares of JPMorgan Chase & Co. $JPM

Spirepoint Private Client LLC increased its stake in JPMorgan Chase & Co. by 13.2% in the fourth quarter, acquiring an additional 3,449 shares to hold a total of 29,562 shares valued at $9.525 million. This comes as JPMorgan reported a strong Q1 earnings beat, though significant insider selling totaling over $22 million in the last 90 days has also been noted. Regulatory overhang from a March 2024 consent order was also recently terminated, removing a risk premium for the company.

Source: MarketBeat
April 18, 2026 | 09:19:56
Category: General

Triad Wealth Partners LLC Boosts Stake in JPMorgan Chase & Co. $JPM

Triad Wealth Partners LLC increased its stake in JPMorgan Chase & Co. by 54.4% in the fourth quarter, bringing their total holdings to 15,964 shares valued at $5.144 million. Despite the institutional buying, the article notes potential headwinds for JPM, including management trimming full-year net interest income guidance and significant insider selling. JPMorgan Chase reported strong Q1 earnings, beating analyst estimates for both EPS and revenue.

Source: MarketBeat
April 18, 2026 | 09:20:00
Category: General

Tudor Investment Corp ET AL Sells 155,435 Shares of PennyMac Mortgage Investment Trust $PMT

Tudor Investment Corp ET AL significantly reduced its stake in PennyMac Mortgage Investment Trust (PMT) by selling 155,435 shares, decreasing its position by 93.1%. Despite this, other hedge funds increased their holdings in PMT. The company recently announced a quarterly dividend of $0.40, yielding 13.3%, and analysts currently hold a consensus "Hold" rating with a target price of $13.60.

Source: MarketBeat
April 18, 2026 | 09:20:04
Category: General

Linde plc stock (IE00BZ12WP82): Is its industrial gases dominance strong enough for steady U.S. inve

Linde plc, a global leader in industrial gases, is highlighted as a strong investment for U.S. and English-speaking investors due to its dominance in critical sectors like electronics, healthcare, and clean energy. The company's diversified business model, robust market share, and strategic focus on sustainability and high-growth markets promise stable returns and defensive growth. Analysts generally view Linde favorably, emphasizing its strong free cash flow and dividend history.

Source: AD HOC NEWS
April 18, 2026 | 09:20:19
Category: General

Target Corp. stock (US87612E1064): Is its everyday essentials model strong enough to unlock new upsi

Target Corp. (US87612E1064) combines value pricing with curated merchandise, offering a defensive play on consumer staples and growth in digital sales. The company's model emphasizes affordable essentials, stylish home goods, and groceries, driving steady foot traffic and customer loyalty. Analysts view Target favorably for its defensive qualities, digital upside, and strong loyalty programs, positioning it as a long-term investment in consumer staples.

Source: AD HOC NEWS
April 18, 2026 | 09:22:39
Category: General

PolyPid Ltd stock (US70450B1035): Is its drug delivery tech strong enough to unlock surgical market

PolyPid Ltd, an Israeli medtech firm, is developing innovative polymer-based drug delivery systems, particularly D-PLEX, to prevent post-surgical infections. The company aims to address the significant costs and complications associated with surgical site infections by delivering antibiotics directly to the wound. Investors are evaluating whether PolyPid's POLYSITEK technology can deliver substantial returns in the volatile biotech market, banking on its potential to revolutionize infection prevention in surgical procedures globally.

Source: AD HOC NEWS
April 18, 2026 | 09:23:54
Category: General

Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside?

Amgen Inc. is positioned for growth due to its focus on innovative biologics and a promising obesity drug pipeline, particularly with its candidate MariTide. The company's core business model leverages recombinant DNA technology for protein-based drugs, ensuring reliable revenue from established treatments while aiming for upside from next-generation therapies. Analysts view Amgen positively, highlighting its resilient portfolio and the potential of its obesity franchise, making it a compelling investment for those seeking both defense and growth in the biotech sector.

Source: AD HOC NEWS
April 18, 2026 | 09:25:06
Category: General

Genuine Parts Company stock (US3724601055): Why does its auto parts dominance matter more now for U.S. investors?

Genuine Parts Company (GPC) is a dominant player in the automotive and industrial aftermarket, benefiting from extending vehicle lifespans and rising repair costs, making it a resilient investment. Its dual business model, extensive distribution network, and proprietary brands position it as a stable portfolio choice, especially for investors seeking dividend growth and exposure to an aging global vehicle fleet. The company's strategic advantage lies in its physical presence and ability to cater to both professional repair shops and DIY customers, fending off purely online competitors.

Source: AD HOC NEWS
April 18, 2026 | 09:28:53
Category: General

Paychex Inc stock (US7043261079): Is its HR tech dominance strong enough to unlock new upside?

Paychex Inc. offers investors exposure to the essential payroll and HR services market, primarily for small to mid-sized businesses in the US and English-speaking markets worldwide. The company's focus on cloud-based solutions, integrated platforms, and compliance expertise positions it as a defensive play within the software-as-a-service space. While facing risks from macroeconomic sensitivity and competition, Paychex's recurring revenue, strong client base, and strategic growth initiatives make it a stable core holding for patient, income-focused investors.

Source: AD HOC NEWS
April 18, 2026 | 09:29:21
Category: General

© Natavest 2025 - 2026